John F Ward, MD, FACS
Department of Urology, Division of Surgery
Present Title & Affiliation
Primary Appointment
Professor, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1991 | Georgetown University, Washington, DC, US, MD |
| 1987 | University of Notre Dame, Notre Dame, Indiana, US, Biology, Bachelor of Science (BS) |
Postgraduate Training
| 2001-2003 | Clinical Fellowship, Urologic-Oncology, Mayo Clinic, Rochester, Minnesota |
| 1993-1998 | Clinical Residency, Urology, Naval Medical Center, San Diego, California |
| 1991-1992 | Clinical Internship, General Surgery, Naval Medical Center, San Diego, California |
Licenses & Certifications
| 2023 | Georgia Composite Medical Board |
| 2023 | Tennessee Board of Medical Examiners |
| 2023 | Arizona Board of Medical Examiners |
| 2021 | Florida Board of Medicine |
| 2007 | TMB |
| 2000 | American Board of Urology |
| 1992 | National Board of Medical Examiners |
Experience & Service
Administrative Appointments/Responsibilities
Program Director, The University of Texas MD Anderson Cancer Center, Houston, Texas
Other Professional Positions
Lead Author, UpToDate, New York, NY, 2012 - Present
Board Member, International Consensus of Experts in Ablative Technology, Denver, CO, 2011 - Present
Advisory Board Member, Dendreon, Las Vegas, NV, 2006 - Present
Advisory Board Member, Abbott Laboratories, Chicago, IL, 2005 - Present
Advisory Board Member, Roche Laboratories, Scottsdale, AZ, 2005 - Present
Commission Resigned, Honorable, United States Navy, 2005 - Present
Promoted, Commander, United States Navy, 2001 - Present
Promoted, Lieutenant Commander, United States Navy, 1995 - Present
Promoted, Lieutenant, United States Navy, 1991 - Present
Commissioned, Ensign, United States Navy, 1987 - Present
Intramural Institutional Committee Activities
Member, Wellness Champion, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Ad hoc Fluroscopy Privilieging Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present
Member - Department of Urology Representative, Division of Surgery Safety Committee, The University of Texas MD Anderson Cancer Center, 2011 - Present
Member, Division of Surgery - Quality Improvement Officer, The University of Texas MD Anderson Cancer Center, 2011 - Present
Director / Member, Department of Urology - Mortality and Morbidity, The University of Texas MD Anderson Cancer Center, 2011 - Present
Member, Ethics Committee, The University of Texas MD Anderson Cancer Center, 2008 - Present
Member, Clinical Research Committee, The University of Texas MD Anderson Cancer Center, 2007 - Present
Member, Department of Urology CRC Review Committee, The University of Texas MD Anderson Cancer Center, 2007 - Present
Member, Institutional Tissue Microarray Desktop Application and Relational Database Committee, The University of Texas MD Anderson Cancer Center, 2007 - Present
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2007 - Present
Member, Structured Clinical Data Steering Committee, The University of Texas MD Anderson Cancer Center, 2007 - Present
Editorial Activities
Co- Editor, Cancers, 2023 - Present
Editor, Frontiers, 2023 - Present
Lead Guest Editor, Prostate Cancer, 2011 - Present
Editorial Board Member, Clinical Genitourinary Cancer, 2010 - Present
Honors & Awards
| 2011 - 2012 | Who's Who in Medicine and Healthcare (8th Edition), Marquis |
| 2010 | America's Top Surgeons 2010, Consumer's Research Council of America |
| 2009 | Who's Who in America 2009, Marquis Who's Who in Medicine and Healthcare |
| 2002 | Young Investigator Scholarship, Academy of Molecular Imaging |
| 2001 - 2003 | Full-Time Out Services Scholarship for the Study of Urologic Oncology, United States Navy |
| 2001 | Navy and Marine Corps Commendation Medal, United States Navy |
| 1995 | First Place, Navy Research Competition, United States Navy |
| 1995 | Second Place, Navy Wide Research Competition, United States Navy |
| 1995 | Navy and Marine Corps Achievement Medal for Outstanding Research by a Resident, United States Navy |
| 1991 | President, Senior Medical Class, Georgetown University |
| 1991 | Ciba-Giegy Award for Leadership, Intelligence and Compassion, Georgetown University |
| 1989 - 1990 | President, Junior Medical Class, Georgetown University |
| 1989 | Alpha Omega Alpha Membership, Georgetown University |
| 1988 - 1989 | Vice-President, Sophomore Medical Class, Georgetown University |
| 1987 - 1991 | Health Professions Scholarship for Study of Medicine, United States Navy |
| 1987 | Knute Rockne Top Student Athlete, University of Notre Dame |
| 1987 | Alpha Epsilon Delta Membership, National Premedical Honor Society |
| 1987 | Theta Alpha Kappa Membership, National Honor Society of Religious Studies of Theology |
| 1984 | Scholar Athlete, Midwest Collegiate Conference |
| 1984 | All-Conference Team, Midwest Collegiate Conference |
| 1983 - 1986 | Dean's List, University of Notre Dame Honors Program, University of Notre Dame |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2024. N/A. Invited. Christopher G. Wood Advances in Urologic Oncology Symposium. Austin, Texas, US.
National Presentations
- 2024. Prostate Fusion Biopsy Systems. Invited. South Central Section AUA. Colorado Springs, Colorado, US.
- 2024. N/A. Invited. Focal Therapy Society of Urologic Robotic Surgeons. Washington D.C, Virginia, US.
- 2024. N/A. Invited. PRO-Talk LIVE. Las Vegas, Nevada, US.
- 2023. N/A. Invited. SUO 24th Annual Meeting. Washington D.C, Virginia, US.
- 2023. N/A. Invited. International Symposium on Focal Therapy and Imaging. Washington D.C, Virginia, US.
- 2023. Oncological Outcomes Following Robotic Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Testicular Caner: A Worldwide Multicenter Study. Invited. 2023 Annual American Urological Association Meeting. Chicago, IL, US.
Formal Peers
- 2013. Cryoablation for Prostate Cancer. Invited, CN.
- 2013. Hands-on Urologic Ultrasound Course.
- 2012. Faculty Instructor/Member. Laurel, Maryland, US.
- 2012. Cryoablation for Prostate Cancer. Invited. Taiwan, TH.
- 2011. Prostate and Renal Cryoablation. Invited. Kuala Lumpur, MY.
- 2011. Cryoablation in Urologic Oncology. Invited. Kuala Lumpur, MY.
- 2011. Focal Therapy Outcomes in Prostate Cancer. Invited. Kuala Lumpur, MY.
- 2011. Case Presentations. Invited. Taipei, TW.
- 2008. Primary Cryosurgery As a Treatment Option for Prostate Cancer. Invited. Boston, MA, US.
- 2008. Testicular Cancer: Observation vs Therapeutic Intervention. Invited. Boston, MA, US.
- 2008. Therapeutic Options for Radiorecurrent Prostate Cancer. Invited. Boston, MA, US.
- 2007. Salvage Radical Prostatectomy: The Gold Standard for Radioresistant Prostate Cancer. Invited. San Juan, PR, US.
- 2007. Prostate Cryotherapy: Has an Old Technique Finally Come of Age?. Invited. San Juan, PR, US.
- 2007. Salvage Prostatectomy in Radiorecurrent Prostate Cancer. Invited. Baton Rouge, LA, US.
- 2007. Salvage Radical Prostatectomy: The Gold Standard of Radioresistant Prostate Cancer. Invited. Baton Rouge, LA, US.
- 2005. Emerging Trends in Locally Advanced Prostate Cancer. Invited. Raleigh, NC, US.
- 2005. PSA Recurrence in the 21st Century. Invited. Raleigh, NC, US.
- Interview-Molecular Load of Pathologically Occult Metastases in Pelvic Lymph Nodes is an Independent Prognostic Marker of Biochemical Failure After Localized Prostate Cancer Treatment. Invited. Houston, TX, US.
Grant & Contract Support
| Date: | 2024 - 2027 |
| Title: | Knowledge Generation Project: A digital twin for the optimal monitoring and radiotherapy of prostate cancer based on personalized computational forecasts (PCATWIN) |
| Funding Source: | National Research Agency, Spanish Ministry of Science, Innovation and Universities |
| Role: | Co-I |
Selected Publications
Peer-Reviewed Articles
- Nieto, Y, Ward, JF, Hofstetter, WL, Rice, D, Karam, JA, Pisters, LL, Vauthey, JN, Shah, AY, Lin, JK, Johns, AC, Araujo, JC, Tu, S, Wang, J, Li, J, Abudayyeh, A, Thall, PF, Bassett Jr, R, Barnett, M, Gulbis, A, Shigle, TL, Ramdial, JL, Popat, UR, Qazilbash, MH, Jones, R, Andersson, BS, Shpall, E, Sheikh, IN, Pagliaro, LC, Campbell, M. High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors. Clinical Cancer Research 32(2):300-311, 2026. e-Pub 2026. PMID: 40853903.
- Lawen, T, Garcia, RS, Smith, MT, Pyo, J, Higgason, N, Robert, M, Chapin, BF, Chery, LJ, Davis, JW, Ward, JF, Pisters, LL, Pettaway, CA, Hahn, AW, Frigo, DE, Wei, P, Daniel-MacDougall, CR, Gregg, JR. Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance. Journal of Urology Publish Ahead of Print, 2026. e-Pub 2026. PMID: 41662578.
- Kraft, IL, Akshintala, S, Gross, A, Dombi, E, Turkbey, B, Bednarova, S, Ward, JF, Yedururi, S, Merino, M, Pinto, PA, Widemann, BC, Shern, JF, Waguespack, SG, Glod, J. The prostate is a common site of disease in patients with MEN2B and medullary thyroid carcinoma. Endocrine-related cancer 33(1), 2026. e-Pub 2026. PMID: 41378514.
- Jackson, J, Sanchez, D, Joon, A, Estecio, MR, Johns, AC, Shah, AY, Campbell, M, Ward, JF, Pisters, LL, Guo, CC, Zhang, M, Millward, NZ, Tu, S. Bilateral Germ Cell Tumor of the Testis. Cells 14(9), 2025. e-Pub 2025. PMID: 40358182.
- Gregg, JR, Newcomb, LF, Wu, R, Dennison, JB, Davis, JW, Pettaway, CA, Pisters, L, Ward, JF, Chapin, BF, Chery, LJ, Urkmez, A, Fang, A, Higgason, N, Troncoso, P, Daniel-MacDougall, CR, Logothetis, CJ, Thompson, TC, Hahn, AW, Liu, M, Zheng, Y, Lin, DW, Hanash, SM, Irajizad, E, Fahrmann, JF. Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance. Biomarker Research 12(1), 2024. e-Pub 2024. PMID: 39522029.
- Ghoreifi A, Sheybaee Moghaddam F, Mitra AP, Khanna A, Singh A, Chavarriaga J, Moon SC, Goolam AS, Chuang R, Rich JM, Baky FJ, Ho M, Roberts J, Gill IS, Porter JR, Ahmadi N, Mehrazin R, Sfakianos JP, Rais-Bahrami S, Bagrodia A, Hamilton RJ, Eggener S, Rawal S, Ward JF, Djaladat H. Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter Study. Eur Urol Focus 11(2):266-272, 2024. e-Pub 2024. PMID: 39551650.
- Gregg JR, Newcomb L, Wu R, Dennison J, Davis JW, Pettaway C, Pisters L, Ward JF, Chapin BF, Chery L, Urkmez A, Fang AM, Higgason N, Troncoso P, Daniel CR, Logothetis C, Thompson TC, Hahn AW, Liu M, Zheng Y, Lin DW, Hanash S, Irajizad E, Fahrmann J. Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance. Biomark Res 12(1):134, 2024. e-Pub 2024. PMID: 39522029.
- Tabet, GC, Zheng, L, Hosseini, H, Ward, JF, Pisters, LL, Campbell, M, Tu, S, Czerniak, BA, Guo, CC. Epithelioid trophoblastic tumor in male patients with germ cell tumor. Human Pathology 153, 2024. e-Pub 2024. PMID: 39461379.
- Jackson JC, Sanchez D, Johns AC, Campbell MT, Aydin AM, Gokden N, Maraboyina S, Muesse JL, Ward JF, Pisters LL, Zacharias NM, Guo CC, Tu SM. Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer. J Clin Med 13(12), 2024. e-Pub 2024. PMID: 38929965.
- Hahn AW, Manyam GC, Chapin BF, Zhang M, Yu Y, Pettaway CA, Chery L, Pisters LL, Ward JF, Gregg JR, Papadopoulos J, Kamat AM, Lozano M, Hoang A, Broom B, Wang X, Huff CD, Logothetis CJ, Troncoso P, Pilie PG, Davis JW. A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates. BJU Int 134(3):449-458, 2024. e-Pub 2024. PMID: 38837608.
- Anselmino, N, Labanca, E, Shepherd, P, Dong, J, Yang, J, Song, X, Nandakumar, S, Kundra, R, Lee, CJ, Schultz, N, Zhang, J, Araujo, JC, Aparicio, A, Subudhi, SK, Corn, P, Pisters, LL, Ward, JF, Davis, JW, Vazquez, ES, Gueron, G, Logothetis, CJ, Futreal, A, Troncoso, P, Chen, Y, Navone, NM. Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series. Clinical Cancer Research 30(10):2272-2285, 2024. e-Pub 2024. PMID: 38488813.
- Gregg JR, Magill R, Fang AM, Chapin BF, Davis JW, Adibi M, Chery L, Papadopoulos J, Pettaway C, Pisters L, Ward JF, Hahn AW, Daniel CR, Bhaskaran J, Zhu K, Guerrero M, Zhang M, Troncoso P. The association of body mass index with tumor aggression among men undergoing radical prostatectomy. Urol Oncol 42(4):116.e1-116.e7, 2024. e-Pub 2024. PMID: 38262868.
- Wang, L, Sanders, JW, Ward, JF, Lee, SR, Poenisch, F, Swanson, DM, Sahoo, N, Zhu, XR, Ma, J, Kudchadker, RJ, Choi, S, Nguyen, Q, Mayo, LL, Shah, SJ, Frank, SJ. A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation Therapy. Cancers 16(3), 2024. e-Pub 2024. PMID: 38339376.
- Deivasigamani S, Kotamarti S, Rastinehad AR, Salas RS, Rosette JJMCH DL, Lepor H, Pinto P, Ahmed HU, Gill I, Klotz L, Taneja SS, Emberton M, Lawrentschuk N, Wysock J, Feller JF, Crouzet S, Kumar M P, Seguier D, Adams ES, Michael Z, Abreu A, Jack Tay K, Ward JF, Shinohara K, Katz AE, Villers A, Chin JL, Stricker PD, Baco E, Macek P, Ahmad AE, Chiu PKF, Crawford ED, Rogers CG, Futterer JJ, Rais-Bahrami S, Robertson CN, Hadaschik B, Marra G, Valerio M, Chong KT, Kasivisvanathan V, Tan WP, Lomas D, Walz J, Guimaraes GC, Mertziotis NI, Becher E, Finelli A, Kasraeian A, Lebastchi AH, Vora A, Rosen MA, Bakir B, Arcot R, Yee S, Netsch C, Meng X, de Reijke TM, Tan YG, Regusci S, Benjamin TGR, Olivares R, Noureldin M, Bianco FJ, Sivaraman A, Kim FJ, Given RW, Dason S, Sheetz TJ, Shoji S, Schulman A, Royce P, Shah TT, Scionti S, Salomon G, Laguna P, Tourinho-Barbosa R, Aminsharifi A, Cathelineau X, Gontero P, Stabile A, Grummet J, Ledbetter L, Graton M, Stephen Jones J, Polascik TJ, Society FT. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement. Eur Urol 84(6):547-560, 2023. e-Pub 2023. PMID: 37419773.
- J Ward J, J Richie J, B Davis B. Update, Initial management of regionally localized intermediate-, high-, and very high-risk prostate cancer and those with clinical lymph node involvement, 2023. e-Pub 2023.
- Siddiqui, BA, Chapin, BF, Jindal, S, Duan, F, Basu, S, Yadav, SS, Gu, A, Espejo, A, Kinder, M, Pettaway, CA, Ward, JF, Tidwell, R, Troncoso, P, Corn, P, Logothetis, CJ, Knoblauch, RE, Hutnick, N, Gottardis, MM, Drake, CG, Sharma, P, Subudhi, SK. Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor). Journal for immunotherapy of cancer 11(3), 2023. e-Pub 2023. PMID: 36948506.
- Ghoreifi A, Mitra AP, McClintock G, Baky F, McDowell Z, Lavallée E, Saoud R, Cai J, Gill IS, Sfakianos J, Porter J, Bagrodia A, Ahmadi N, Eggener S, Ward JF, Djaladat H. Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study. Urol Oncol 41(2):111.e7-111.e14, 2023. e-Pub 2023. PMID: 36437156.
- Siddiqui, Bilal, Ward, John F. Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor). Journal for ImmunoTherapy of Cancer, 2023. e-Pub 2023.
- Moore JA, Lehner MJ, Anfossi S, Datar S, Tidwell RS, Campbell M, Shah AY, Ward JF, Karam JA, Wood CG, Pisters LL, Calin GA, Tu SM. Predictive capacity of a miRNA panel in identifying teratoma in post-chemotherapy consolidation surgeries. BJUI Compass 4(1):81-87, 2023. e-Pub 2023. PMID: 36569509.
- Westerman, ME, Bree, KK, Msaouel, P, Kukreja, JB, Mantaring, C, Rukundo, I, Gonzalez, MG, Gregg, JR, Casteel, KN, Matin, S, Lafleur, AD, Best, RN, Crump, LD, Cunningham, JM, Saucedo, MA, Valle, DD, Varghese, R, Adibi, M, Chapin, BF, Chery, LJ, Davis, JW, Dinney, CP, Graber, WJ, Kamat, A, Karam, JA, Navai, N, Papadopoulos, JN, Pettaway, CA, Pisters, LL, Smith III, T, Ward, JF, Westney, OL, Wood, CG. Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis. Journal of Urology 208(4):886-895, 2022. e-Pub 2022. PMID: 36082549.
- Westerman ME, Yevich SM, Dori Y, Ward JF, Pisters LL, Karam JA, Wood CG, Avritscher R, Matin SF. Lymphangioembolization for iatrogenic chylous ascites after retroperitoneal urological surgery. BJU Int 129(5):585-587, 2022. e-Pub 2022. PMID: 34962705.
- Mustafa, MO, Ward, JF, Davis, JW, Pettaway, CA, Pisters, LL. Transperineal saturation prostate biopsy in treated and untreated patients. Palestinian Medical and Pharmaceutical Journal 5(2):117-124, 2022. e-Pub 2022.
- Tan, WP, Rastinehad, A, Klotz, L, Carroll, P, Emberton, M, Feller, JF, George, AK, Gill, IS, Gupta, RT, Katz, AE, Lebastchi, AH, Marks, LS, Marra, G, Pinto, PA, Song, DY, Sidana, A, Ward, JF, Sanchez-Salas, R, Rosette, Jl, Polascik, TJ, Katz, AE, Aminsharifi, A, Lebastchi, AH, Abreu, A, Villers, A, Schulman, A, Rastinehad, A, George, A, Oto, A, Turkbey, B, Malavaud, B, Muller, BG, Moore, CM, Eberli, D, Margolis, D, Song, D, Lomas, D, Orabi, H, Lepor, H, Tan, HM, Jambor, I, De La Rosette, JJ, Grummet, J, Feller, JF, Ward, J, Colemen, J, Gregg, JR, Tay, KJ, Marks, LS, Deane, L. Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer. Urologic Oncology: Seminars and Original Investigations 39(11):781.e17-781.e24, 2021. e-Pub 2021. PMID: 33676851.
- Gregg JR, Borregales LD, Choi H, Lozano M, McRae SE, Venkatesan AM, Davis JW, Nogueras-Gonzalez GM, Pisters LL, Ward JF. Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes. World J Urol 39(9):3259-3264, 2021. e-Pub 2021. PMID: 33454813.
- Chin JL, Lavi A, Metcalfe MJ, Siddiqui K, Dewar M, Petros FG, Li R, Nogueras González GM, Wang X, Nair SM, Ward JF, Pisters L. Long-Term Outcomes of Whole Gland Salvage Cryotherapy for Locally Recurrent Prostate Cancer following Radiation Therapy: A Combined Analysis of Two Centers. J Urol 206(3):646-654, 2021. e-Pub 2021. PMID: 33908799.
- Li R, Duplisea JJ, Petros FG, González GMN, Tu SM, Karam JA, Huynh TT, Ward JF. Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer. Eur Urol Oncol 4(4):651-658, 2021. e-Pub 2021. PMID: 31412007.
- Kang, H, Jo, NH, Bamashmos, AS, Ahmed, M, Sun, J, Ward, JF, Choi, H. Accuracy of Prostate Magnetic Resonance Imaging. European Urology Open Science 27:53-60, 2021. e-Pub 2021. PMID: 33899028.
- Urkmez A, Ward JF, Choi H, Troncoso P, Inguillo I, Gregg JR, Altok M, Demirel HC, Qiao W, Kang HC. Temporal Learning Curve of a Multidisciplinary Team for MRI-TRUS Fusion Prostate Biopsy. BJU Int 127(5):524-527, 2021. e-Pub 2021. PMID: 33340435.
- Baiomy A, Jensen CT, Ward JF, Chasen BA, Ravizzini GC. Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer. Clin Nucl Med 46(4):355-357, 2021. e-Pub 2021. PMID: 33323736.
- Gregg, JR, Zhang, X, Chapin, BF, Ward, JF, Kim, J, Davis, JW, Daniel-MacDougall, CR. Adherence to the Mediterranean diet and grade group progression in localized prostate cancer. Cancer 127(5):720-728, 2021. e-Pub 2021. PMID: 33411364.
- Shapiro, DD, Gregg, JR, Lim, A, Nogueras Gonzalez, G, Choi, H, Kang, H, Inguillo, IA, Chapin, BF, Davis, JW, Ward, JF. Comparing confirmatory biopsy outcomes between MRI-targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillance. BJU International 127(3):340-348, 2021. e-Pub 2021. PMID: 32357283.
- Wang, AZ, Lebastchi, AH, O’Connor, LP, Ahdoot, M, Mehralivand, S, Yerram, NK, Taneja, SS, George, AK, Sanchez-Salas, R, Ward, JF, Laguna, MP, De La Rosette, JJ, Pinto, PA. Making a case “for” focal therapy of the prostate in intermediate risk prostate cancer. World journal of urology 39(3):729-739, 2021. e-Pub 2021. PMID: 33388878.
- Gregg, JR, Surasi, DS, Childs, A, Moll, N, Ward, JF, Kim, J, Daniel-MacDougall, CR, Logothetis, CJ, Bathala, TK, Davis, JW. The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance. Journal of Urology 205(1):122-128, 2021. e-Pub 2021. PMID: 32718204.
Invited Articles
- Ahmad1 AE, Yee2 C, Wysock3 JS, Ward4 JF. Defining Candidates for Partial Gland Prostate Ablation – A Critical Challenge for Focal Therapy. AUANews, 2023. e-Pub 2023.
- Wysock J, Ahmad A, Ward J, Yee S. Overview of Patient Selection for Targeted Prostate Cancer Therapy. Focal Therapy, 2023. e-Pub 2023.
- Ward JF. Integrative molecular analyses of the MD Anderson Prostate Cancer Patient-Derived Xenograft (MDA PCa PDX) Series. Nature Journal, 2023. e-Pub 2023.
Other Articles
- Anselmino N, Labanca E, Shepherd P, Dong J, Yang J, Song X, Nandakumar S, Kundra R, Lee C, Schultz N, Zhang J, Araujo J, Aparicio A, Subudhi S, Corn P, Pisters L, Ward J, Davis J, Vazquez E, Gueron G, Logothetis C, Futreal A, Troncoso P, Chen Y, Navone AN Integrative molecular analyses of the MD Anderson Prostate Cancer Patient-Derived Xenograft (MDA PCa PDX) Series, 2023.
Editorials
- Ward JF. Initial management of regionally localized intermediate-, high-, and very high-risk prostate cancer and those with clinical lymph node involvement. UpToDate, 2023.
Abstracts
- Lorenzo G, Wu C, Yung JP, Ward JF, Gomez H, Reali A, Yankeelov TE, Venkatesan AM, Hughes TJR. Personalized MRI-informed forecasting of prostate cancer progression during active surveillance. AACR 2024 abstract - Prostate cancer forecasting, 2024. e-Pub 2024.
- Tu S, Trikannad AK, Vellanki S, Hussain M, Malik N, Singh SR, Jillella A, Obulareddy S, Malapati S, Bhatti SA, T Atiq KAA. Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care, 2024. e-Pub 2024.
- Wang L, Sanders J, Ward JF, Lee SR, Poenisch F, Swanson DM, Sahoo N, Zhu XR, Ma J, Kudchadker RJ, Choi SL, Nguyen Q, Mayo LL, Shah SJ, Frank SJ. A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation Therapy, 2024. e-Pub 2024.
- Lorenzo G, Wu C, Yung JP, Ward JF, Gomez H, Reali A, Yankeelov TE, Venkatesan AM, R Hughes ATJ. PERSONALIZED IMAGING-INFORMED FORECASTING OF PROSTATE CANCER PROGRESSION DURING ACTIVE SURVEILLANCE, 2024. e-Pub 2024.
- Umbreit EC, A Siddiqui †B, J Hwang †M, Joon AY, Maity T, Westerman ME, Merriman KW, Alhasson H, Uthup J, Guo T, Moore JA, Ward JF, Karam JA, Wood CG, Pisters LL, Zhang M, Tu S. Subsequent Malignant Neoplasms (SMN) in Patients with Germ Cell Tumor of the Testis (TGCT): Implications on a Genetic vs Stem Cell Origin of Cancers, 2024. e-Pub 2024. PMID: 33327406.
- Ward JF, Wang 1L, Sanders 2J, Lee 3S, Poenisch 4F, Sahoo 5N, Zhu 5X, Ma 5J, J Kudchadker 3R, Wang 5J, Choi 3S, Nguyen 6Q, Mok 6H, Tang 6C, McGuire 6S, Hoffman 6K, Hassenzadeh 6C, Mayo 6L, Shah 6S, Chronowski 6G, 6, Frank6 SJ. EARLY CLINICAL EXPERIENCE OF NOVEL POSITIVELY VISIBLE MULTI-IMAGING MODALITY FIDUCIAL MARKERS IN STEREOTACTIC MRI-ASSISTED RADIOSURGERY FOR PROSTATE CANCER. SCS AUA, 2023. e-Pub 2023.
- Brisbane W, MD, Thompson C, MD FACS MD, Raman S, MD, Sisk A, DO, Rettig M, MD, Reiter R, MD Mirabela Rusu MD, PhD, Sonn G, MD, Fan R, Ward PJ, MD Brian Wodlinger MD, PhD. Comprehensive Health Intelligence Model for Enhanced Real-time Cancer Assessment (CHIMERA), 2023. e-Pub 2023.
- G Lorenzo G, C Wu C, JP Yung JP, JF Ward JF, H Gomez H, A Reali A, TE Yankeelov TE, AM Venkatesan AM, TJR Hughes TJR. Personalized MRI-informed predictions of prostate cancer growth during active surveillance. Society for Mathematical Biology, 2023. e-Pub 2023.
- G Lorenzo G, C Wu C, JP Yung JP, JF Ward JF, H Gomez H, A Reali A, TE Yankeelov TE, AM Venkatesan AM, TJR Hughes TJR. Personalized MRI-informed predictions of prostate cancer growth during active surveillance, 2023. e-Pub 2023.
- G Lorenzo G, C Wu C, JP Yung JP, JF Ward JF, H Gomez H, A Reali A, TE Yankeelov TE, AM Venkatesan AM, TJR Hughes TJR. Patient-specific, organ-scale forecasting of prostate cancer growth in active surveillance. AACR Annual Meeting 2023, 2023. e-Pub 2023.
- Ghoreifi A, Mitra A, Khanna A, Langleben C, Rich J, McClinton G, Baky F, McDowell Z, Ho M, Roberts J, Moghaddam FS, Haque T, Gill I, Eggener S, Porter J, Ahmadi N, Mehrazin R, Sfakianos J, Bagrodia A, Hamilton R, Rawal S, Ward J, Djaladat H. Oncological Outcomes Following Robotic Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Testicular Caner: A Worldwide Multicenter Study. American Urological Association, 2023. e-Pub 2023.
- G Lorenzo G, C Wu C, JP Yung JP, JF Ward JF, H Gomez H, A Reali A, TE Yankeelov TE, AM Venkatesan AM, TJR Hughes TJR. Patient-specific, imaging-informed computational forecasting of prostate cancer growth during active surveillance. 17th US National Conference on Computational Mechanics (USNCCM17), 2022. e-Pub 2022.
- Moore JA, Slack RS, Lehner MJ, Campbell MT, Shah AY, Zhang M, Guo CC, Ward JF, Karam JA, Wood CG, Pisters LL, Tu SM. Very Late Recurrence in Germ Cell Tumor of the Testis: Lessons and Implications. Cancers (Basel) 14(5), 2022. e-Pub 2022. PMID: 35267435.
- Shapiro DD, Davis JW, Williams WH, Chapin BF, Ward JF, Pettaway CA, Gregg JR. Increased body mass index is associated with operative difficulty during robot-assisted radical prostatectomy. BJUI Compass 3(1):68-74, 2022. e-Pub 2022. PMID: 35475154.
- Altok M, Demirel C, Kang HC, Choi H, John D, Inguillo IA, Davis JW, Ward JF. Impact of MRI/US fusion-guided prostate biopsy on biopsy-naïve patients: A single urologist's experience. BJUI Compass 3(1):19-25, 2022. e-Pub 2022. PMID: 35475153.
- Pisters PW, Ranasinghe W, Wei W, Wood CG, Matin SF, Ward JF, Pisters LL. Long-term renal functional outcomes following ureteroureterostomy performed during multi-organ resection for non-urothelial cancers. BJUI Compass 2(5):348-354, 2021. e-Pub 2021. PMID: 35474874.
- Chang CM, McIntosh AG, Shapiro DD, Davis JW, Ward JF, Gregg JR. Does a screening digital rectal exam provide actionable clinical utility in patients with an elevated PSA and positive MRI?. BJUI Compass 2(3):188-193, 2021. e-Pub 2021. PMID: 35475129.
Book Chapters
- Ward, JF. Prostate Focal Therapy. In: Definitions and Common Terminology, 275-280, 2025.
Patient Reviews
CV information above last modified July 22, 2026